A Study of BR111 in Patients With Advanced Malignancies

Clinical trial NCT06937957 · RECRUITING

Trial details

NCT number: NCT06937957
Sponsor: BioRay Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Malignancies

Start date: 2025-04-24
Primary completion: 2027-10-09
Enrollment: 166

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.